Proteios Technology Revenue and Competitors

Proteios Technology is a spin-out from the University of Washington developing a flexible protein technology platform. Proteios’ protein technology is based on a patented dodecapeptide (affinity tag) that exhibits micromolar affinity for silica substrates and eluded using low-cost, biologically-safe reagents. When incorporated to either the N- or C-terminus of a protein, the tag provides a convenient handle for automated protein manipulations, including protein/biopharmaceutical purification, cell enrichment/depletion for cellular therapies, microtiter-based high-throughput (parallel) protein purification, printing protein or antibody chips for HTS, immobilized biocatalysis, and biosensors. Proteios is initially focused on providing easy-to-use, affordable and rapid kits to purify recombinant proteins, where we have a competitive advantage in cost (5x-10x less expensive), throughput (12x improvement), quality (50% improvement in failure rate), purity (> 90%), yield (> 15 mg), and safety (absence of heavy-metal impurities by using biologically-safe reagents).